Discover 1,776 paid clinical trials in High Point, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,776
STRIDE Biorepository
for
Anemia, Sickle Cell
Location: Chapel Hill NC, Durham NC, Charlottesville VA,
Sponsor: Emory University
Sex: All
Age: 15 - 40
Code: NCT02843347
Recruiting
Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma
Location: Chapel Hill NC, Atlanta GA, Detroit MI, Rochester NY,
Sponsor: Opna Bio LLC
Sex: All
Age: 18+
Code: NCT06433947
Phase 1, Recruiting
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
for
Ovarian Cancer
Location: Chapel Hill NC, Savannah GA, Towson MD, Centerville OH,
Sponsor: Daiichi Sankyo
Sex: Female
Age: 18+
Code: NCT06819007
Phase 3, Recruiting
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
for
Atherosclerosis
Location: Chapel Hill NC, Pittsburgh PA, Nashville TN,
Sponsor: Genentech, Inc.
Sex: All
Age: 18+
Code: NCT07448038
Phase 2, Recruiting
Optimizing Telehealth-delivery of a Weight Loss Intervention in Older Adults
for
Obesity, Multiple Chronic Conditions
Location: Chapel Hill NC
Sponsor: University of North Carolina, Chapel Hill
Sex: All
Age: 65 - 70+
Code: NCT06044571
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
New
Physiology-directed Epinephrine Dosing in Pediatric Cardiac Arrest
for
Cardiac Arrest (CA)
Location: Chapel Hill NC, Richmond VA, Atlanta GA, Columbus OH,
Sponsor: Children's Hospital of Philadelphia
Sex: All
Age: 0 - 18
Code: NCT07890610
Recruiting
Inspiring New Science In Guiding Healthcare in Turner Syndrome Registry
for
Turner Syndrome
Location: Chapel Hill NC, Washington DC, Columbus OH,
Sponsor: University of Colorado, Denver
Sex: Female
Age: 0+
Code: NCT05052606
Recruiting
A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature
for
Idiopathic Short Stature
Location: Chapel Hill NC, Columbia SC, Washington D.C. DC,
Sponsor: BioMarin Pharmaceutical
Sex: All
Age: 3 - 11
Code: NCT06382155
Phase 2, Recruiting
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
for
Type 2 Diabetes
Location: Chapel Hill NC, Columbia SC, Greenville SC,
Sponsor: Eli Lilly and Company
Sex: All
Age: 10 - 17
Code: NCT06739122
Phase 3, Recruiting
Optimal Ventilation for Cardiac Arrest
for
Cardiac Arrest (CA)
Location: Chapel Hill NC, Richmond VA, Atlanta GA, Columbus OH,
Sponsor: Children's Hospital of Philadelphia
Sex: All
Age: 0 - 18
Code: NCT07114510
Recruiting
A Study to Investigate Efficacy and Safety of KP-001 Compared With Placebo in Patients Aged ≥2 Years With Common VM, Common LM, or KTS/CLOVES Syndrome
for
Venous Malformations, Lymphatic Malformations,
Location: Chapel Hill NC, Charleston SC, Morgantown WV,
Sponsor: Kaken Pharmaceutical
Sex: All
Age: 2+
Code: NCT07285005
Phase 3, Recruiting
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
for
Hematologic Malignancies
Location: Chapel Hill NC, Greenville SC, Newnan GA, Birmingham AL,
Sponsor: Sellas Life Sciences Group
Sex: All
Age: 12+
Code: NCT04588922
Phase 1, Phase 2, Recruiting
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
Sponsor: UNC Lineberger Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT06860880
Recruiting
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
for
B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma,
Location: Chapel Hill NC, Columbus OH, Nashville TN,
Sponsor: Vironexis Biotherapeutics Inc.
Sex: All
Age: 13 - 70+
Code: NCT06533579
Phase 1, Phase 2, Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
for
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma,
Location: Chapel Hill NC, Salem VA, Atlanta GA, Pittsburgh PA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07221149
Phase 2, Phase 3, Recruiting
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
for
Breast Neoplasms, Neoplasm Metastasis
Location: Chapel Hill NC, Cary NC, Wilson NC, Asheville NC,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07174336
Phase 3, Recruiting
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Location: Chapel Hill NC, Durham NC, West Columbia SC,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06119581
Phase 3, Recruiting
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
for
Peripheral T-Cell Lymphoma, Not Otherwise Specified,
Location: Chapel Hill NC, Atlanta GA, Baltimore MD, Pittsburgh PA,